• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮用受铅污染的私酿酒后用二巯基丁二酸治疗铅性脑病

Management of Lead Encephalopathy with DMSA After Exposure to Lead-Contaminated Moonshine.

作者信息

Arnold Justin, Morgan Brent

机构信息

Department of Emergency Medicine, Emory University, 531 Asbury Circle, Annex Building Suite N340, Atlanta, GA, 30322, USA.

Georgia Poison Center, 50 Hurt Plaza, Suite 600, Atlanta, GA, 30303, USA.

出版信息

J Med Toxicol. 2015 Dec;11(4):464-7. doi: 10.1007/s13181-015-0493-9.

DOI:10.1007/s13181-015-0493-9
PMID:26245877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4675610/
Abstract

BACKGROUND

Lead encephalopathy is a severe manifestation of lead poisoning that can present with altered mental status and seizures and has been associated with illicit moonshine consumption. Lead encephalopathy has traditionally been treated using dimercaprol (British anti-Lewisite, BAL) and calcium disodium ethylenediaminetetraacetic acid (CaNa2EDTA).

CASE REPORT

We describe a patient with lead encephalopathy related to lead-contaminated moonshine consumption, who was treated using dimercaptosuccinic acid (DMSA) due to a national shortage of CaNa2EDTA. A 66-year-old woman presented to a hospital with headache, irritability, and altered mental status. On hospital day 16, she was found to have a whole blood lead concentration of 148.2 μg/dL and a 24-h urine lead concentration of 232 μg/day. Due to a national shortage of CaNa2EDTA, the patient was given one dose of BAL and then started on DMSA via nasogastric tube. She dramatically improved over 4 days and was subsequently transitioned to oral DMSA and outpatient treatment. One day prior to discharge, her whole blood lead concentration was 47.2 μg/dL and her mental status was normal. DMSA was used in lieu of CaNa2EDTA to treat the patient with lead encephalopathy. The patient subsequently experienced clinical improvement and declining whole blood level concentrations.

CONCLUSION

Further prospective studies are needed to compare the efficacy of DMSA versus CaNa2EDTA in patients with lead encephalopathy.

摘要

背景

铅中毒性脑病是铅中毒的一种严重表现,可出现精神状态改变和癫痫发作,且与饮用非法私酿酒有关。传统上,铅中毒性脑病采用二巯丙醇(英国抗路易氏剂,BAL)和乙二胺四乙酸二钠钙(CaNa2EDTA)进行治疗。

病例报告

我们描述了一名因饮用受铅污染的私酿酒而患铅中毒性脑病的患者,由于全国范围内CaNa2EDTA短缺,该患者使用二巯基丁二酸(DMSA)进行治疗。一名66岁女性因头痛、易怒和精神状态改变入院。在住院第16天,发现她的全血铅浓度为148.2μg/dL,24小时尿铅浓度为232μg/天。由于全国范围内CaNa2EDTA短缺,该患者先接受了一剂BAL治疗,然后通过鼻胃管开始使用DMSA治疗。她在4天内病情显著改善,随后转为口服DMSA并接受门诊治疗。出院前一天,她的全血铅浓度为47.2μg/dL,精神状态正常。使用DMSA替代CaNa2EDTA治疗铅中毒性脑病患者。该患者随后临床症状改善,全血铅水平浓度下降。

结论

需要进一步进行前瞻性研究,以比较DMSA与CaNa2EDTA在铅中毒性脑病患者中的疗效。

相似文献

1
Management of Lead Encephalopathy with DMSA After Exposure to Lead-Contaminated Moonshine.饮用受铅污染的私酿酒后用二巯基丁二酸治疗铅性脑病
J Med Toxicol. 2015 Dec;11(4):464-7. doi: 10.1007/s13181-015-0493-9.
2
A comparative study of edetate calcium disodium and dimercaptosuccinic acid in the treatment of lead poisoning in adults.依地酸钙钠与二巯丁二酸治疗成人铅中毒的对比研究。
Clin Toxicol (Phila). 2018 Nov;56(11):1143-1149. doi: 10.1080/15563650.2018.1478424. Epub 2018 Jun 11.
3
Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.二巯基琥珀酸(二巯基丁二酸;DMSA)用于无机铅中毒治疗
Clin Toxicol (Phila). 2009 Aug;47(7):617-31. doi: 10.1080/15563650903174828.
4
A Case of Severe Lead Encephalopathy with Cardiac Arrest Managed During a Chelation Shortage.重度铅中毒性脑病伴心跳骤停 1 例,在螯合剂短缺期间进行治疗。
J Med Toxicol. 2024 Jan;20(1):49-53. doi: 10.1007/s13181-023-00970-2. Epub 2023 Oct 16.
5
Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication.用消旋-2,3-二巯基丁二酸治疗儿童铅中毒的对照研究。
J Pediatr. 1992 Jan;120(1):133-9. doi: 10.1016/s0022-3476(05)80618-3.
6
A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.依地酸钙钠与二巯基丁二酸治疗无机铅中毒的比较。
Clin Toxicol (Phila). 2009 Nov;47(9):841-58. doi: 10.3109/15563650903321064.
7
Comparison of dimercaptosuccinic acid and calcium disodium ethylenediaminetetraacetic acid versus dimercaptopropanol and ethylenediaminetetraacetic acid in children with lead poisoning.二巯基琥珀酸和乙二胺四乙酸二钠钙与二巯丙醇和乙二胺四乙酸在儿童铅中毒治疗中的比较。
J Pediatr. 1997 Jun;130(6):966-71. doi: 10.1016/s0022-3476(97)70285-3.
8
Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning.口服二巯丁二酸(二巯丁二酸)在成人无机铅中毒中的应用。
QJM. 2009 Oct;102(10):721-32. doi: 10.1093/qjmed/hcp114. Epub 2009 Aug 20.
9
Effects of calcium disodium EDTA and meso-2,3-dimercaptosuccinic acid on tissue concentrations of lead for use in treatment of calves with experimentally induced lead toxicosis.乙二胺四乙酸二钠钙和消旋-2,3-二巯基丁二酸对实验性诱导铅中毒犊牛组织铅浓度的影响,用于治疗犊牛。
Am J Vet Res. 2003 Jun;64(6):672-6. doi: 10.2460/ajvr.2003.64.672.
10
Combined therapeutic potential of meso-2,3-dimercaptosuccinic acid and calcium disodium edetate on the mobilization and distribution of lead in experimental lead intoxication in rats.中-2,3-二巯基丁二酸与依地酸钙钠联合对大鼠实验性铅中毒中铅的动员与分布的治疗潜力
Fundam Appl Toxicol. 1995 May;25(2):233-40. doi: 10.1006/faat.1995.1059.

引用本文的文献

1
Trends in Shortages of Lead Chelators From 2001 to 2022.2001年至2022年铅螯合剂短缺趋势。
J Pediatr Pharmacol Ther. 2024 Jun;29(3):306-315. doi: 10.5863/1551-6776-29.3.306. Epub 2024 Jun 10.
2
A Case of Severe Lead Encephalopathy with Cardiac Arrest Managed During a Chelation Shortage.重度铅中毒性脑病伴心跳骤停 1 例,在螯合剂短缺期间进行治疗。
J Med Toxicol. 2024 Jan;20(1):49-53. doi: 10.1007/s13181-023-00970-2. Epub 2023 Oct 16.
3
Potential diagnostic biomarkers for lead-induced hepatotoxicity and the role of synthetic chelators and bioactive compounds.铅诱导肝毒性的潜在诊断生物标志物以及合成螯合剂和生物活性化合物的作用。
Toxicol Res (Camb). 2023 Mar 11;12(2):178-188. doi: 10.1093/toxres/tfad014. eCollection 2023 Apr.
4
Biomimetic Antidote Nanoparticles: a Novel Strategy for Chronic Heavy Metal Poisoning.仿生解毒纳米颗粒:慢性重金属中毒的新策略。
AAPS PharmSciTech. 2022 Nov 30;24(1):12. doi: 10.1208/s12249-022-02466-8.
5
In vitro activity of EDTA and TOL-463 against Neisseria gonorrhoeae.乙二胺四乙酸(EDTA)和TOL-463对淋病奈瑟菌的体外活性
Diagn Microbiol Infect Dis. 2019 Apr;93(4):369-371. doi: 10.1016/j.diagmicrobio.2018.10.021. Epub 2018 Nov 10.

本文引用的文献

1
Antidote shortages in the USA: impact and response.美国的解毒剂短缺:影响与应对措施
J Med Toxicol. 2015 Mar;11(1):144-6. doi: 10.1007/s13181-013-0372-1.
2
Description of 3,180 courses of chelation with dimercaptosuccinic acid in children ≤ 5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme data.尼日利亚北部赞法拉州5岁及以下重度铅中毒儿童3180例二巯基丁二酸螯合治疗疗程描述:项目数据回顾性分析
PLoS Med. 2014 Oct 7;11(10):e1001739. doi: 10.1371/journal.pmed.1001739. eCollection 2014 Oct.
3
A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.依地酸钙钠与二巯基丁二酸治疗无机铅中毒的比较。
Clin Toxicol (Phila). 2009 Nov;47(9):841-58. doi: 10.3109/15563650903321064.
4
Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning.二巯基琥珀酸(二巯基丁二酸;DMSA)用于无机铅中毒治疗
Clin Toxicol (Phila). 2009 Aug;47(7):617-31. doi: 10.1080/15563650903174828.
5
Lead contaminated moonshine: a report of Bureau of Alcohol, Tobacco and Firearms analyzed samples.
Vet Hum Toxicol. 2004 Apr;46(2):89-90.
6
The metabolism of C14 labeled ethylenediaminetetraacetic acid in human beings.人体中碳14标记的乙二胺四乙酸的代谢
J Lab Clin Med. 1954 Apr;43(4):566-71.
7
The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood.螯合剂在儿童急慢性铅中毒治疗中的应用。
J Pediatr. 1968 Jul;73(1):1-38. doi: 10.1016/s0022-3476(68)80036-8.
8
2,3-Dimercaptosuccinic acid treatment of heavy metal poisoning in humans.2,3-二巯基丁二酸对人类重金属中毒的治疗作用。
Med Toxicol Adverse Drug Exp. 1988 Nov-Dec;3(6):499-504. doi: 10.1007/BF03259898.
9
Succimer, an oral lead chelator.二巯基琥珀酸,一种口服铅螯合剂。
Clin Pharm. 1991 Dec;10(12):914-22.